Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study.
Nakayama Y, Onishi A, Yamamoto W, Yoshikawa A, Shiba H, Yoshida N, Son Y, Shirasugi I, Maeda T, Katsushima M, Hashimoto M, Etani Y, Itami T, Nozaki Y, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Matsuda S, Morinobu A.
Nakayama Y, et al. Among authors: matsuda s.
Clin Exp Med. 2024 May 10;24(1):97. doi: 10.1007/s10238-024-01360-w.
Clin Exp Med. 2024.
PMID: 38727756
Free PMC article.